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Kainate receptor activation depresses synaptic release of neu-
rotransmitter at a number of synapses in the CNS. The mech-
anism underlying this depression is controversial, and both
ionotropic and metabotropic mechanisms have been sug-
gested. We report here that the AMPA/kainate receptor ago-
nists domoate (DA) and kainate (KA) cause a presynaptic de-
pression of glutamatergic transmission at CA33CA1 synapses
in the hippocampus, which is not blocked by the AMPA recep-
tor antagonist GYKI 53655 but is blocked by the AMPA/KA
receptor antagonist CNQX. Neither a blockade of interneuronal
discharge nor antagonists of several neuromodulators affect
the depression, suggesting that it is not the result of indirect
excitation and subsequent release of a neuromodulator. Pre-
synaptic depolarization, achieved via increasing extracellular
K1, caused a depression of the presynaptic fiber volley and an
increase in the frequency of miniature EPSCs. Neither effect
was observed with DA, suggesting that DA does not depress
transmission via a presynaptic depolarization. However, the
effects of DA were abolished by the G-protein inhibitors
N-ethylmaleimide and pertussis toxin. These results suggest
that KA receptor activation depresses synaptic transmission at
this synapse via a direct, presynaptic, metabotropic action.
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Neurotransmitter receptors in the CNS can be separated into two
broad classes: ionotropic receptors, which are coupled to ligand-
gated conductances, and metabotropic receptors, which couple to
GTP-binding proteins. Kainate receptors (KARs) are ionotropic
glutamate receptors that, in addition to having conventional
postsynaptic actions, are thought to act as presynaptic inhibitors
of transmitter release at a number of synapses in the CNS (for
review, see Frerking and Nicoll, 2000). The mechanisms under-
lying this depression are controversial. Both direct actions of
presynaptic KARs (Chittajallu et al., 1996; Rodrı´guez-Moreno et
al., 1997; Schmitz et al., 2000) and indirect actions of somatoden-
dritic KARs (Frerking et al., 1999; Chergui et al., 2000; Schmitz
et al., 2000) have been proposed to account for this presynaptic
effect. The depression has also been suggested to be the down-
stream result of presynaptic depolarization via the conventional
ionotropic actions of KARs (Chittajallu et al., 1996; Kamiya and
Ozawa, 1998; Schmitz et al., 2000) or alternatively via a novel
KAR-coupled metabotropic cascade (Rodrı´guez-Moreno and
Lerma, 1998; Rodrı´guez-Moreno et al., 2000).
One difficulty in interpreting the effects of KAR activation is
the frequent presence of somatodendritic KARs on the presyn-
aptic neurons, which can lead to a number of different types of
use-dependent depression. Glutamatergic CA33CA1 synapses
in the hippocampus provide a good system in which to study the
KAR-induced depression, because the somatodendritic region of
the presynaptic CA3 cells can be removed by microdissection. At
these synapses, the KAR agonists kainate (KA) and domoate
(DA) both induce a depression of glutamate release (Chittajallu
et al., 1996; Kamiya and Ozawa, 1998; Vignes et al., 1998) that is
not accompanied by changes in presynaptic excitability, as as-
sessed by changes in the extracellular fiber volley (Kamiya and
Ozawa, 1998; Vignes et al., 1998), but is accompanied by a
decrease in presynaptic Ca21 influx (Kamiya and Ozawa, 1998).
However, these results do not exclude the possibility that the
KAR-induced depression is the indirect result of neuromodula-
tors released from CA1 interneurons, which fire intensely in
response to KAR activation (Cossart et al., 1998; Frerking et al.,
1998), nor do they address the relative contributions of ionotropic
and metabotropic mechanisms to the depression.
In this study, we examine the mechanism underlying the KAR-
induced presynaptic inhibition at glutamatergic CA33CA1 syn-
apses in the hippocampus. We confirm the previously described
presynaptic actions of DA. We find that the depressant action of
DA cannot be explained by the indirect release of a number of
different neuromodulators and also cannot be explained by an
increase in interneuronal discharge, suggesting that this presyn-
aptic action is the direct result of KARs at or near the presynaptic
terminal. We find that the selective action of DA on the field
EPSP (fEPSP) is not mimicked by presynaptic depolarization
with extracellular K1, which depresses the fEPSP and the fiber
volley in parallel. However, the effects of DA are abolished by the
G-protein inhibitors N-ethylmaleimide (NEM) and pertussis
toxin. These results suggest that KARs depress release at this
synapse via a direct, metabotropic action.
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MATERIALS AND METHODS
Slice preparation and recording techniques. Hippocampal slices 300–400
mm thick were prepared from 2- to 12-week-old Sprague Dawley rats as
described (Frerking et al., 1998). After .1 hr of recovery time, a cut was
made between area CA1 and area CA2/CA3 to remove somatic effects of
KA on CA3 pyramidal cells, and slices were transferred to a submersion-
type recording chamber perfused at room temperature with a solution
consisting of (in mM): 119 NaCl, 26 NaHCO3, 10 glucose, 2.5 KCl, 4
CaCl2, 4 MgSO4, and 1.0 NaH2PO4, bubbled with 95% O2–5% CO2. For
whole-cell recording, patch electrodes (2–5 MV) were filled with a
solution adjusted to pH 7.2, 270–290 mOsm, containing (in mM): 117.5
Cs gluconate, 10 tetraethylammonium chloride, 10 HEPES, 8 NaCl, 5
QX-314Cl, 4 MgATP, 2.5 CsCl, 0.3 Na3GTP, and 0.2 EGTA. Patch
electrodes were filled with the external solution to monitor extracellular
field potentials. Field experiments were done both in the presence and
absence of 100 mM picrotoxin, which had no effect on the depressant
action of domoate (data not shown). All whole-cell experiments on
glutamatergic transmission were done in the presence of 100 mM
picrotoxin.
Stimulation and whole-cell recording techniques in slices were similar
to those described in Frerking et al. (1998). EPSCs were evoked every
15–20 sec and were filtered at 2 kHz and digitized at 5 kHz. Data were
analyzed on-line using Igor Pro (WaveMetrics, Inc., Lake Oswego, OR)
and off-line using Igor Pro and Sigma Plot (Jandel Scientific, San Rafael,
CA). K 1-sensitive microelectrodes were manufactured and tested as
described previously (Lux and Neher, 1973; Heinemann et al., 1977).
Data analysis. All data are presented as the mean 6 SEM. Significance
was assessed at p , 0.05, using the Student’s t test and Pearson’s product
moment correlation. EPSC amplitudes were calculated by subtracting a
baseline period preceding stimulation from a region of 2 msec during the
peak of the EPSC. 1/CV 2, where CV is the coefficient of variation, was
calculated with noise subtraction. Paired-pulse facilitation was measured
as the ratio of amplitudes of a second EPSC over the first, minus one,
converted to a percentage. Miniature EPSCs were detected using the
Mini Analysis Program (Synaptosoft, Inc., Leonia, NJ) and a detection
threshold of 5–10 pA, depending on the noise level. Field EPSP (fEPSP)
slope measurements were made using a time window of the initial 1–2
msec of the fEPSP, set at the start of the experiment; fiber volley
amplitude measurements were made using the peak of the fiber volley.
Experiments using pharmacological manipulations that did not affect the
DA-induced depression were pooled together with control experiments
and treated as a single population where appropriate. The depolarization
caused by increasing extracellular K 1 was estimated using the Goldman–
Hodgkin–Katz voltage equation, assuming that the relative resting per-
meability of sodium in the bouton is ;1/20th that of potassium and
concentrations of K 1 and Na 1 in the bouton are 120 and 10 mM,
respectively.
Pertussis toxin injections. Pertussis toxin was injected into the hip-
pocampus of rats 2–3 d before slice preparation, as described (Pitler and
Alger, 1994). Briefly, rats were anesthetized with sodium pentobarbital
(50 mg/kg) and placed in a stereotaxic apparatus. A small hole was
drilled through the skull over the dorsal right hippocampus, and three
injections (1 ml each) of pertussis toxin (1 mg/ml) were made at the co-
ordinates relative to bregma listed in Pitler and Alger (1994). The
injections were made directly into the hippocampus, rather than into the
ventricle, because this has been reported to lead to more effective
penetration of pertussis toxin into the tissue without adverse side effects
(Pitler and Alger, 1994). The rats were then allowed to recover, and slices
from the injected hippocampus were made and used 2–3 d later. Only
slices with track marks from the injection needle were used, to ensure
that the pertussis toxin had been injected in the hippocampus near the
site of recording.
RESULTS
Previous studies have reported that the AMPA/KA receptor
agonist DA, when applied at a low dose of 200 nM, specifically
activates kainate receptors (Bureau et al., 1999). We therefore
examined this dose of DA on the AMPA receptor (AMPAR)-
mediated EPSC recorded in CA1 pyramidal cells (Fig. 1A; n 5 6)
and the AMPAR-mediated fEPSP recorded extracellularly (see
Fig. 2A; n 5 8). The results from these two different measure-
ments were indistinguishable ( p . 0.2) and when pooled together
gave an average depression of ;40% (Fig. 1C; 39 6 5%; n 5 14)
for AMPAR-mediated transmission, similar to that described by
Kamiya and Ozawa (1998). To confirm that this low dose of DA
was not causing the depression via activation of AMPARs, we
examined the effects of DA on NMDA receptor (NMDAR)-
mediated EPSCs in the presence of the AMPAR-selective antag-
onist GYKI 53655, at a concentration (10 mM) that blocks
AMPAR function by . 90%, as assessed by blockade of the
AMPAR-mediated fEPSP (n 5 4; data not shown), but is widely
agreed to have minimal effects on KARs (Paternain et al., 1995;
Wilding and Huettner, 1995). DA under these conditions caused
a depression of the NMDAR-mediated EPSC (Fig. 1B–D; n 5 4)
that was indistinguishable from the effects on AMPAR-mediated
transmission in the absence of GYKI 53655 ( p . 0.5), indicating
that AMPARs are not involved in the depression induced by DA.
However, in the presence of the AMPA/KA receptor antagonist
CNQX (100 mM; n 5 4), the effects of DA on the NMDAR-
mediated EPSC were abolished (Fig. 1C; p , 0.02). The actions
of DA were also not mediated via activation of other glutamate
receptors, because neither the NMDAR antagonist APV (100
mM; n 5 5) nor a combination of the metabotropic glutamate
receptor antagonists methyl-4-carboxyphenylglycine (MCPG)
and cyclopropyl-4-phosphonophenylglycine (CPPG) (1.3 and
0.2 mM, respectively; n 5 4) had any effect on the depression
(Fig. 1C).
In previous studies, KAR activation has been reported to result
in a substantial decrease in the input resistance of CA1 pyramidal
cells (Frerking et al., 1999). However, the majority of this effect
was removed by the GABAA receptor antagonist picrotoxin,
which was present in all whole-cell recordings in the present
Figure 1. KAR activation depresses glutamatergic transmission at
CA33CA1 synapses. A, Averaged, stimulus-evoked AMPAR-mediated
EPSCs are depressed by 200 nM DA. B, Averaged, stimulus-evoked
NMDAR-mediated EPSCs are depressed by 200 nM DA in the presence
of 10 mM GYKI 53655 (GYKI ). C, The depressant action of DA is not
blocked by GYKI 53655, APV, or a combination of MCPG and CPPG
but is blocked by CNQX. Except for the data in GYKI 53655, which
examined NMDAR-mediated EPSCs, the results include data on
AMPAR-mediated EPSCs and fEPSPs that were pooled together. D, The
NMDAR-mediated EPSC amplitude ( filled circles) is compared with the
input resistance (open circles) as a function of time in the presence of 10
mM GYKI 53655. Domoate application is shown by the horizontal line.
amp., Amplitude.
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experiments. To examine more closely a possible role of changes
in the input resistance in the currently examined KAR-induced
depression, we compared the effects of DA on the input resistance
and the NMDAR-mediated EPSC recorded in the presence of
GYKI 53655 (Fig. 1D). Under these experimental conditions, the
holding current changed by only 27 6 16 pA, and there was no
significant reduction in the input resistance (Fig. 1D, open circles)
despite a robust decrease in the EPSC amplitude (Fig. 1D, filled
circles). It therefore seems unlikely that the KAR-induced de-
pression of synaptic transmission is mediated to any appreciable
degree by changes in passive membrane properties. DA also did
not cause any change in the frequency of spontaneous EPSCs
(data not shown).
The KAR-induced depression has been reported to be presyn-
aptic, primarily because of associated changes in short-term plas-
ticity (Kamiya and Ozawa, 1998; Vignes et al., 1998). We con-
firmed that DA increases paired-pulse facilitation (Fig. 2A,B; p ,
0.01; n 5 23), consistent with a presynaptic locus of action. We
also found that DA caused a substantial reduction in the quantal
content contributing to the AMPAR-mediated EPSC, as assessed
by changes in the 1/CV2 ratio of the EPSC (Fig. 2C; p , 0.01; n 5
6). To assess for possible postsynaptic effects, we examined the
effects of DA on the amplitude of miniature EPSCs (mEPSCs);
there was no change in the amplitude of mEPSCs after DA
application (Fig. 2D; n 5 5; see below). These results, collectively
with the results in Figure 1 showing that the NMDAR and
AMPAR components of the EPSC are depressed to a similar
extent and also showing that KAR activation does not cause a
significant change in the input resistance under these conditions,
provide strong evidence that the depressant effect of DA at this
synapse is mainly, if not entirely, mediated via a presynaptic
mechanism.
The results described thus far assess KAR activation via the
use of the agonist DA and address the potential activation of
AMPARs via the use of 10 mM GYKI 53655. To extend further
the pharmacological correlation of the observed depression with
the known properties of KARs, we examined the effects of 10 mM
KA on NMDAR-mediated EPSCs. Because of the lower speci-
ficity of KA for KARs over AMPARs, we used a higher concen-
tration of GYKI 53655 (100 mM) to remove completely the
possibility of AMPAR activation. Under these conditions, we
found that KA caused a substantial depression of the EPSC,
similar in magnitude and time course to that induced by DA (Fig.
3A,B, filled circles; n 5 10). This depression, as expected, was
blocked by CNQX (Fig. 3B, open circles; n 5 4). Also, consistent
with results using DA, KA caused a decrease in 1/CV2 (Fig. 3C;
n 5 10). The depression of the NMDAR-mediated EPSC was
also associated with changes in short-term plasticity (data not
shown). The similarity of the actions of KA and DA, the sensi-
tivity to CNQX, and the resistance to GYKI 53655 all provide
Figure 2. KAR activation reduces the probability of release. A, Top, DA
has a larger effect on the first of two fEPSPs. Bottom traces show the
paired-pulse responses after scaling to the first fEPSP. B, A summary of
23 experiments examining AMPAR-mediated transmission, pooled from
both field and whole-cell recordings, shows the change in paired-pulse
facilitation as a function of time. C, DA causes a decrease in 1/CV 2 of the
EPSC that is correlated with the decrease in mean EPSC amplitude.
Individual experiments are shown. D, DA has no effect on mEPSC
amplitude.
Figure 3. Kainate depresses the NMDA receptor-mediated EPSC. A,
Averaged, stimulus-evoked NMDA receptor-mediated EPSCs are de-
pressed by 10 mM KA in the presence of 100 mM GYKI 53655. B, The
KA-induced depression is shown as a function of time under control
conditions ( filled circles) and in the presence of 100 mM CNQX (open
circles). C, KA causes a decrease in 1/CV 2 of the EPSC that is correlated
with the decrease in mean EPSC amplitude. Individual experiments are
shown.
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strong support for the idea that the agonist-induced depression is
mediated by KARs.
Although the experiments performed so far indicate that the
depression ultimately is caused by presynaptic expression mech-
anisms, it is not clear from these data whether or not the effects
of KAR activation are caused by the direct activation of presyn-
aptic KARs on the terminal or the indirect activation of soma-
todendritic KARs on some other cell population in the slice
preparation that then releases a neuromodulator that acts het-
erosynaptically on the terminal. We therefore examined the sen-
sitivity of the DA-induced depression to antagonists for a number
of different neuromodulators known to affect synaptic transmis-
sion in area CA1. We found that neither a combination of
8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and SCH 50911 (to
block adenosine 1A and GABAB receptors, respectively; n 5 5)
nor a combination of atropine, 1-(2-methoxyphenyl)-4-[4-(2-
phthalimido)butyl]piperazine (NAN-190), sulpiride, and N-nitro-
arginine [to block muscarinic acetylcholine receptors, 5-HT1A
receptors, dopamine D2 receptors, and nitric oxide (NO) syn-
thase, respectively; n 5 5] had any effect on the depression of the
fEPSP (Fig. 4A).
Although the absence of any effect of these antagonists in-
creases confidence that the effect of DA on the fEPSP is direct, it
remains possible that DA activates a population of neurons to
release some neuromodulator that has not been blocked by these
cocktails. Hippocampal interneurons in particular are known to
release a wide variety of neuromodulatory substances upon acti-
vation and are also known to be activated by somatodendritic
KARs. This activation has been reported to affect indirectly both
inhibitory (Frerking et al., 1999) and excitatory (Schmitz et al.,
2000) transmission at other synapses in the hippocampus. We
therefore performed experiments to address more generally the
possibility that the effects of DA are indirectly mediated by
interneuronal activation. We found that, as expected if KARs
cause interneuronal discharge, DA dramatically increased the
spontaneous IPSC (sIPSC) frequency onto CA1 pyramidal cells
(Fig. 4B; 1066 6 228% of control values; n 5 4). It has been
shown previously (Frerking et al., 1998) that KAR activation of
interneuronal discharge can be prevented by a high divalent
composition (8 mM Ca21 and 17 mM Mg21) of the extracellular
solution without altering the release probability, presumably by
increasing the charge screening. We confirmed that a solution
containing 8 mM Ca 21 and 17 mM Mg21 prevented the DA-
induced increase in interneuronal discharge, as assessed by the
increase in sIPSC frequency (Fig. 4B; 93 6 13% of control values;
n 5 4). However, the high-divalent solution had no effect on the
DA-induced depression of the fEPSP (Fig. 4C,D; n 5 7), dem-
onstrating that this effect is not downstream of interneuronal
discharge. We therefore conclude that the depression is not
mediated indirectly via the release of any of the widely considered
neuromodulators in the hippocampus and is independent of in-
terneuronal activity, suggesting a direct action of DA on the
presynaptic terminal.
Because KARs are ionotropic receptors and the effects of DA
appear to be direct, we wondered whether or not the DA-induced
depression could be explained by a presynaptic depolarization.
One consequence of presynaptic depolarization that has been
widely suggested is that a sufficiently large depolarization would
inactivate sodium channels and diminish spike amplitude; how-
ever, KAR activation has been reported to depress transmission
without affecting the presynaptic fiber volley, which is an extra-
cellular measurement of the compound action potential (Kamiya
and Ozawa, 1998; Vignes et al., 1998). One difficulty in interpret-
ing these results, however, is that under normal conditions the
fiber volley is much smaller than the fEPSP, making a comparison
of these parameters difficult in the same experiment. We there-
fore examined the effects on the fiber volley and the fEPSP
simultaneously in the continued presence of 1–2 mM GYKI
53655, to reduce the size of the fEPSP relative to that of the fiber
volley. Under these conditions, DA caused a depression of the
fEPSP, whereas the fiber volley was unaffected (Fig. 5A1,B,D; n 5
6). To test the relative sensitivities of the fiber volley and the
fEPSP, we then added tetrodotoxin to the solution, which will
depress Na channels in presynaptic axons and therefore also
transmitter release; we found that TTX caused a parallel reduc-
tion of the fiber volley and the fEPSP (Fig. 5A2,B,D; n 5 6),
confirming the sensitivity of the fiber volley under these condi-
tions. We then performed a similar comparison of the fiber volley
and fEPSP during stepwise increases in the extracellular K1
concentration, to depolarize the presynaptic terminals. We found
that, in contrast to DA, extracellular K1 did not depress the
fEPSP selectively; concentrations of extracellular K1 that de-
pressed the fEPSP also depressed the fiber volley (Fig. 5C,D; n 5
6). The observation that extracellular K1 does not mimic DA
suggests that the DA-induced depression is not mediated by a
presynaptic depolarization.
To perform a more general test for a DA-induced presynaptic
depolarization, we examined the effects of DA on mEPSC fre-
quency. It is well established that presynaptic depolarization
increases mEPSC frequency. The relationship between presynap-
Figure 4. KAR activation does not depress transmission via indirect
interneuronal activation. A, A summary of experiments shows that the
normal effect of DA (mean 6 SEM shown as solid horizontal line 6 dotted
horizontal lines) on fEPSPs is unaffected by both a cocktail of antagonists
for GABAB receptors (SCH 50911, 20 mM) and adenosine receptors
(DPCPX, 10 mM) and a cocktail of antagonists for muscarinic receptors
(atropine, 10 mM), NO synthase [N-nitro-L-arginine (L-NNA), 100 mM],
dopamine receptors (sulpiride, 100 nM), and serotonin receptors (NAN-
190, 50 mM). B, Spontaneous IPSCs are recorded at 0 mV. After addition
of 200 nM DA, a large increase in sIPSC frequency is observed. In a
solution containing high divalent concentrations (8 mM Ca and 17 mM
Mg), the DA-induced increase in sIPSC frequency is absent in a different
cell. C, The depressant action of DA on fEPSPs is unaffected by the
solution with high divalents. D, The normal effect of DA on fEPSPs ( filled
circles) is unaffected by the solution with high divalents (open circles).
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tic depolarization and spontaneous release is steep starting at
approximately 250 mV (Frerking et al., 1997); however, under
normal conditions the presynaptic voltage is well below this
threshold, and thus small depolarizations will have little effect on
mEPSC frequency. We therefore examined mEPSCs in the pres-
ence of 15 mM extracellular K1 to bring the presynaptic voltage
closer to this sensitive range of voltages. Under these conditions,
DA did not have any resolvable effect on mEPSC frequency (Fig.
6A,C; n 5 5). To ensure that this assay is in fact sensitive to small
presynaptic depolarizations, an additional 5 mM K1 was applied,
which would be expected to cause a presynaptic depolarization of
;5 mV (see Materials and Methods). Unlike DA, this modest
increase in K1 caused a rapid and easily resolvable increase in the
frequency of mEPSCs (Fig. 6B,C; n 5 4). We conclude that DA
under these conditions does not resolvably depolarize the presyn-
aptic terminal.
If KARs are in fact present on the terminal, they should affect
the fiber volley with sufficient activation. We therefore examined
the fiber volley during application of 20 mM DA, in the presence
of 100 mM GYKI 53655 to remove completely the possibility of
AMPA receptor activation at this high dose and also in the
presence of 100 mM cadmium to block calcium influx and thereby
prevent all depolarization-evoked transmitter or modulator re-
lease. Under these conditions, DA causes a strong reduction of
the fiber volley (Fig. 7A,B; n 5 5). Although this effect could be
attributable to a direct depolarizing action of KARs on the
presynaptic terminal, an alternative is that somatodendritic KAR
activation causes an increase in K1 efflux that then causes the
depolarization. We therefore measured the extracellular K1 lev-
els in response to DA application using K1-sensitive microelec-
trodes. The K1 levels rose by ;4 mM in response to the DA
application (Fig. 7C1; n 5 4); however, bath application of 4 mM
KCl did not mimic the effects of DA on the fiber volley (Fig. 7C2;
Figure 5. KAR activation depresses synaptic transmission without af-
fecting fiber excitability. A, The fEPSP was examined in the presence of
submaximal concentrations of GYKI 53655 to enhance resolution of the
fiber volley. A1, However, DA depressed the fEPSP without affecting the
fiber volley. A2, In contrast, TTX depressed both the fEPSP and the fiber
volley. B, A summary of the experiments in A is shown. The fEPSP (open
circles) was depressed by both DA and TTX, but the fiber volley ( filled
circles) was affected only by TTX. Note that the fiber volley and fEPSP are
decreased by TTX in parallel, suggesting that the depression of the fEPSP
by TTX is the result of decreased fiber excitability rather than synaptic
inhibition. fEPSP measurements shown after the break are renormalized
to 100% at the arrow to correct for a slight (;10%) overshoot in recovery
after DA application (data not shown). C, A summary of experiments
with elevated extracellular K 1 is shown. The fEPSP (open circles) and
fiber volley ( filled circles) were similarly depressed by slowly increasing
the extracellular KCl concentration in steps from 2.5 mM (control) to 5.5,
6.5, 7.5, 8.5, and 9.5 mM. The potentiation of the fEPSP after washout was
seen consistently but not studied further. D, A summary of all experi-
ments comparing the fEPSP and fiber volley is shown. Black circles are
experiments with DA, white circles are experiments with TTX, and gray
circles are experiments with KCl. The dotted lines represent selective
effects on the synapse (horizontal line) or on the fiber (diagonal line). fv,
Fiber volley.
Figure 6. KAR activation by 200 nM DA does not resolvably depolarize
the presynaptic terminal. A, mEPSCs are shown in control conditions, in
which the concentration of K 1 has been increased to 15 mM to bring the
presynaptic membrane potential into a range in which small depolariza-
tions will cause an increase in Ca-dependent mEPSCs (see text). DA has
no effect on the mEPSC frequency. B, Addition of 5 mM KCl, correspond-
ing to an ;5 mV depolarization, causes a pronounced increase in the
frequency of mEPSCs in a different cell. C, A summary of experiments
comparing the effects of DA ( filled circles) and 5 mM KCl (open circles) on
mEPSC frequency is shown.
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n 5 5), indicating that the DA-induced increase in extracellular
K1 cannot explain the DA-induced reduction of the fiber volley.
These results indicate that the presynaptic terminals do have
kainate receptors, which with sufficient activation cause substan-
tial depolarization of the terminal; however, lower doses of DA
do not cause a resolvable depolarization but nevertheless depress
transmitter release.
If DA depresses transmitter release without causing a detect-
able depolarization, what is the mechanism mediating this inhib-
itory action? Rodrı´guez-Moreno and Lerma (1998) have
suggested that presynaptic kainate receptors can depress trans-
mitter release from interneurons in the hippocampus via the
depolarization-independent activation of a G-protein-coupled
cascade. We therefore tested the effects of the G-protein inhibitor
NEM (200 mM) on the DA-induced depression of the fEPSP.
NEM has complex effects on baseline synaptic transmission (Fig.
8A; n 5 6), causing first an increase, probably because of inhibi-
tion of the tonic depressant action of adenosine, and then a
decrease, probably because of a lower-affinity inhibition of the
exocytotic protein N-ethylmaleimide-sensitive factor, which is
required for transmitter release. Because of these complex effects,
the effect of NEM on the DA-induced depression of the fEPSP
was assessed by comparing the fEPSP as a function of time during
DA application with the fEPSP as a function of time during
application of vehicle at the same time window, after 15 min of
NEM incubation (Fig. 8A, shaded box). During this time period,
the fEPSP runs down by ;20% in NEM (Fig. 8B,C, filled circles;
n 5 6). Application of DA did not have any further effect on the
fEPSP (Fig. 8B,C, open circles; n 5 6), indicating that NEM
prevents the effects of DA. To illustrate this point more clearly,
we corrected the fEPSP measurements in NEM during the DA
application by subtracting the effects of NEM alone during the
same time period (Fig. 8D, filled circles). The corrected values
show no effect of DA on the fEPSP in NEM, and this is clearly
different from the depressant action of DA in the absence of
NEM (Fig. 8D, open circles).
To test further for the involvement of G-proteins, we examined
the effects of the G-protein inhibitor pertussis toxin on the DA-
induced depression of the fEPSP. Pertussis toxin, which selec-
tively blocks Gi/Go-mediated processes, is reported to have very
limited penetration in intact tissue, and previous reports have
indicated that injection of pertussis toxin directly into the hip-
pocampus 1–2 d before experiments is required to obtain full
effectiveness of this toxin in brain slices. We therefore injected
pertussis toxin into the hippocampus of 8- to 12-week-old rats at
three injection sites 2–3 d before experiments. We found, consis-
tent with the results using NEM, that DA had no effect on fEPSPs
in slices from pertussis toxin-injected rats (Fig. 9, filled circles; n 5
7); in contrast, DA caused a robust depression in age-matched
controls (Fig. 9, open circles; n 5 6). We conclude that activation
Figure 7. Strong KAR activation depresses the fiber volley. A, a, The
fiber volley was recorded in the presence of 100 mM GYKI 53655 and 100
mM CdCl2. b, After application of 20 mM DA, the fiber volley was
substantially depressed. c, The fiber volley recovered fully after washout.
B, A summary of the experiments in A is shown. C1, The depression of the
fiber volley cannot be explained by K 1 efflux. DA (20 mM) caused an
increase in K 1 levels of ;4 mM, as measured by K 1-sensitive microelec-
trodes. C2, Application of 4 mM KCl under these conditions has no effect
on the fEPSP.
Figure 8. NEM blocks the depressant action of 200 nM DA. A, After a
control period (a), NEM affects baseline synaptic transmission, causing
first an increase (b), and then a decrease (c). During the time indicated by
the shaded box, either DA or vehicle was applied. B, fEPSPs run down
during the vehicle application as a function of time in NEM (top traces),
and no further effect is seen when DA is applied instead of the vehicle
solution (bottom traces). C, A summary of experiments, in which the
fEPSP slope is normalized to that during the 5 min preceding application
of DA or vehicle. Experiments in which DA was applied (open circles) are
no different from those in which vehicle was applied ( filled circles). The
total time window in C corresponds to the region enclosed by vertical
dotted lines in A. D, After removal of the baseline effects of NEM on
synaptic transmission by subtracting the depression caused by DA from
the depression caused by the vehicle, DA has no effect on the fEPSP in
NEM-treated slices ( filled circles). For comparison, the normal effect of
DA in control conditions from Figure 4 D is shown (open circles).
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of an NEM- and pertussis toxin-sensitive G-protein is required
for the DA-induced depression of glutamate release.
DA-induced G-protein activation could lead to a depression of
synaptic transmission via the well described, direct interaction
between the bg G-protein subunits and calcium channels; alter-
natively, Rodrı´guez-Moreno and Lerma (1998) have suggested
that a PKC activation downstream of G-protein activity is essen-
tial for the actions of KARs at inhibitory synapses. We therefore
examined the effects of preincubating the slices with the broad-
spectrum serine/threonine protein kinase inhibitor 1-(5-iso-
quinolinesulfonyl)-2-methylpiperazine (H-7) and found that it
had no effect on the depressant action of DA [Fig. 10A,B; control
slices (n 5 8), filled circles; treated slices (n 5 6), open circles]. To
ensure that the H-7 was effectively blocking protein kinase activ-
ity, we examined its effects on the presynaptic potentiation
induced by the adenylate cyclase activator forskolin, coapplied
with the phosphodiesterase inhibitor IBMX (Chavez-Noriega
and Stevens, 1994). As reported previously, forskolin and IBMX
caused a substantial potentiation of the fEPSP under control
conditions (Fig. 10C,D, filled circles; n 5 5); however, after pre-
incubation with H-7, this effect was strongly reduced (Fig. 10C,D,
open circles; n 5 5), confirming the effectiveness of H-7 in the
present experiments. We conclude that protein kinases do not
appear to be required for the DA-induced depression of gluta-
mate release.
DISCUSSION
We have performed experiments to elucidate the mechanism by
which KAR activation depresses excitatory synaptic transmission
at CA33CA1 synapses in the hippocampus. It has been reported
previously that KARs cause a presynaptic depression of trans-
mitter release, because KAR activation depresses release from
synaptosomes (Chittajallu et al., 1996), acts on both the
AMPAR- and NMDAR-mediated components of the EPSC,
alters short-term plasticity (Kamiya and Ozawa, 1998; Vignes et
al., 1998), and depresses presynaptic Ca21 influx (Kamiya and
Ozawa, 1998). Our results are entirely in agreement with this
previous literature. We have confirmed that KAR agonists can
depress both components of the EPSC and alter short-term plas-
ticity, and we have also found that this depression is associated
with a reduction in quantal content, as assessed by 1/CV2 mea-
surements. The absence of any KAR-induced change in input
resistance, coupled with the absence of any effect of KAR acti-
Figure 9. Pertussis toxin blocks the depressant action of 200 nM DA. A,
Averaged fEPSPs in slices from pertussis toxin-injected rats (A1) and
age-matched controls (A2) are shown in the presence and absence of DA.
B, A summary of experiments using slices from pertussis toxin-injected
rats ( filled circles) and slices from age-matched controls (open circles) is
shown. PTX, Pertussis toxin.
Figure 10. Protein kinases are not involved in the DA-induced depres-
sion of synaptic transmission. A, Averaged fEPSPs are shown before and
after application of 200 nM DA in control conditions (top traces) and after
incubation in the protein kinase inhibitor H-7 (bottom traces). B, A
summary of the experiments in A is shown. The DA-induced depression
in the presence of H-7 (open circles) is not different from the depression
in control experiments ( filled circles). C, Averaged fEPSPs are shown
before and after application of forskolin and IBMX in control and
H-7-treated slices. Forskolin and IBMX together (each at 150 mM) cause
a potentiation of the fEPSP, which is strongly reduced in H-7-treated
slices. D, A summary of experiments shows that the enhancement caused
by forskolin and IBMX ( filled circles) is greatly reduced by H-7 (open
circles).
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vation on mEPSC amplitude, suggests that little, if any, of the
depressant action of KARs on excitatory transmission is
postsynaptic.
The observation that KARs cause a presynaptic depression of
synaptic transmission does not necessarily indicate that KARs
are located on the presynaptic terminal; activation of KARs on
other cells could cause the release of a presynaptic neuromodu-
lator that acts heterosynaptically. This has in fact been a proposed
mechanism of the KAR-induced depressant action in a few
systems (Frerking et al., 1999; Chergui et al., 2000; Schmitz et al.,
2000) (but see Rodrı´guez-Moreno et al., 2000). Three broad lines
of experimental evidence argue against such a scenario in the
present experiments. First, the depression induced by DA is
unaffected by antagonism of a number of neuromodulators in the
hippocampus. Second, the depression is unaffected by increasing
the divalent composition, a manipulation that reduces cell excit-
ability and prevents KAR-dependent interneuronal spiking. Fi-
nally, strong KAR activation via a high dose of DA can affect
presynaptic fiber excitability even in the presence of cadmium to
block calcium influx-dependent neuromodulator release, provid-
ing direct evidence of the existence of presynaptic KARs in this
system. These experiments strongly suggest that the KAR-
induced depression of glutamate release at CA33CA1 synapses
is caused by the direct activation of presynaptic KARs.
One possible indirect action of KARs that our experiments
have not addressed is the release of neuromodulators because of
calcium influx via calcium-permeable KARs, located either at the
soma or on the terminals of some other population of synapses.
However, the somatodendritic KARs on interneurons do not
have the characteristically nonlinear I–V relations of calcium-
permeable KARs (Frerking et al., 1998), making their involve-
ment in such a cascade unlikely. Moreover, if KARs on presyn-
aptic terminals were calcium permeable, their activation would
lead to a large increase in the frequency of miniature PSCs; such
an increase has not been reported for mEPSCs (this study) or
miniature IPSCs (Rodrı´guez-Moreno et al., 1997; Cossart et al.,
1998; Frerking et al., 1998; Bureau et al., 1999) onto CA1 pyra-
midal cells. We therefore think this scenario unlikely, although
we cannot exclude the possibility that some unidentified popula-
tion of cells that do not synapse onto CA1 pyramidal cells could
have these receptors and release a modulator that causes the
effect.
Because of the evidence supporting a direct presynaptic action
of KARs, it is surprising that the effects of KAR activation, at
least at low doses, are distinct from those of presynaptic depolar-
ization via increasing extracellular K1. Although DA depresses
synaptic transmission without affecting the presynaptic fiber vol-
ley, presynaptic depolarization affects both in parallel (see Fig.
5C). Moreover, even modest presynaptic depolarizations (;5
mV) cause a detectable change in mEPSC frequency in the
presence of 15 mM extracellular K1, but DA does not. However,
a higher dose of DA robustly depresses the fiber volley, suggesting
that strong activation of KARs can depolarize the terminal
sufficiently to have presynaptic ionotropic effects. These results
indicate that low doses of DA that are sufficient to depress
synaptic transmission cause no detectable depolarization of the
presynaptic terminal and that the depression of release does not
occur via an ionotropic mechanism. Moreover, the observation
that elevated K1 depressed fiber excitability to the same extent
that it depressed transmission suggests that presynaptic depolar-
ization at this synapse has little direct effect on the synapse but
instead acts mainly by preventing spike initiation and/or propa-
gation. This would occur if axonal Na channels were inactivated
at more hyperpolarized potentials than were presynaptic Ca
channels. Strikingly, different results have been observed at mossy
fiber synapses in the hippocampus, where synaptic transmission is
depressed by levels of depolarization that enhance the fiber volley
(Schmitz et al., 2000).
The evidence that KARs do not depress release via ionotropic
mechanisms suggests that KARs activate a metabotropic signal-
ing pathway, and the observation that G-protein inhibitors block
the KAR-dependent synaptic depression is consistent with this
suggestion. The sensitivity of the KAR-induced depression to
pertussis toxin implicates the Gi/Go subtype of G-protein in the
effect. It is noteworthy that binding studies have suggested a
functional coupling between this subclass of G-protein and
KARs in hippocampal membranes (Cunha et al., 1999).
AMPARs have also been shown to couple to G-proteins (Wang
et al., 1997; Kawai and Sterling, 1999). A major unresolved issue
is how these receptors might activate G-proteins, because they
have little structural similarity to the classical metabotropic re-
ceptors. A frequently proposed solution is that an accessory
protein acts as a link between G-proteins and KARs, but so far a
protein with this role has not been identified. Another caveat
concerning the involvement of G-proteins is that the pharmaco-
logical blockade of the effect by G-protein inhibitors could indi-
cate that KARs activate a G-protein but could alternatively result
from a nonspecific action of the inhibitors or a dependence of
KAR activity on G-proteins. Direct biochemical evidence will be
required to establish unequivocally KARs as activators of
G-proteins and to identify the protein–protein interactions that
are involved.
We propose that presynaptic K ARs couple to Gi/Go
G-proteins, which causes the G-protein to dissociate into the a
and b/g subunits. Because our results indicate that protein kinases
are not required in the signaling cascade, we suggest that the b/g
subunits directly bind to and inhibit presynaptic Ca21 channels
and thereby depress release. This would be consistent with the
observation that KAR activation depresses stimulus-evoked pre-
synaptic Ca21 transients at this synapse (Kamiya and Ozawa,
1998). We further suggest that presynaptic KARs may be sparsely
distributed presynaptically, so that strong activation of KARs is
required to resolve the ionotropic activity of the KAR, but weak
activation appears to be sufficient to generate resolvable metabo-
tropic activity. This higher sensitivity of the metabotropic path-
way is presumably caused by the substantial biochemical amplifi-
cation that takes place at the level of receptor–G-protein
coupling, although we cannot at present exclude the alternative
that separate, high-affinity metabotropic and low-affinity iono-
tropic KARs are present.
The degree to which this model can be extrapolated to other
systems is unclear. KARs have been reported to activate a
metabotropic cascade to depress release at inhibitory synapses
onto CA1 pyramidal cells (Rodrı´guez-Moreno and Lerma, 1998;
Cunha et al., 2000; Rodrı´guez-Moreno et al., 2000). However,
because GABAergic interneurons are strongly excited by KAR
activation (Cossart et al., 1998; Frerking et al., 1998; Bureau et al.,
1999) and at least some of the inhibition induced by KARs has
been proposed to occur via the indirect activation of metabo-
tropic GABAB receptors caused by that excitation (Frerking et
al., 1998, 1999), to what extent a direct presynaptic metabotropic
action accounts for the KA-induced depression at these synapses
is controversial. KAR activation is known to activate indirectly
metabotropic cascades at other synapses (Chergui et al., 2000;
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Schmitz et al., 2000). Presynaptic KAR activation has also been
reported to modulate transmitter release via ionotropic mecha-
nisms (Kamiya and Ozawa, 2000; Schmitz et al., 2000). It there-
fore seems likely that KAR-dependent modulation of transmitter
release at different synapses operates via different mechanisms.
In conclusion, we have provided evidence that presynaptic
KARs depress glutamate release at CA33CA1 synapses via a
depolarization-independent metabotropic cascade. The condi-
tions under which these receptors are activated and the role that
they play remain unclear. However, an autoreceptive function
seems likely because of the presynaptic location of these receptors
at terminals releasing their endogenous agonist. KARs are widely
thought to play a role in epileptiform activity, particularly in area
CA3 of the hippocampus. The depressant action of the presyn-
aptic receptors described here will tend to reduce transmission of
epileptiform activity from CA3 to CA1, in conjunction with the
previously described “overinhibitory” action of KARs on inter-
neurons (Cossart et al., 1998). These results suggest that KARs,
depending on their location and mechanism of action, both pro-
mote and reduce excitability in the hippocampus.
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